Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd Immunotherapy of Cancer Conference (ITOC3) /
Reprogramming the cancer microenvironment with vaccine-based therapy

21st - 23rd Mar 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.04.16
Views: 1413

Prof Lei Zheng - John Hopkins Institute Baltimore, USA

Prof Lei Zheng speaks with ecancer and his research into vaccine therapies to treat pancreatic cancer.

Pancreatic cancer is notoriously resistant to many treatments, including checkpoint inhibitors.

Prof Zheng reports that using combined vaccine alongside anti-PD1 therapies primes the tumour microenvironment, increasing sensitivity and drug uptake.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation